Evidence map›Paper›PMID 33087155›Full record

ArticleCritical care (London, England)2020

COVID-19: What Iodine Maps From Perfusion CT can reveal-A Prospective Cohort Study.

Mario G Santamarina, Dominique Boisier Riscal, Ignacio Beddings, Roberto Contreras, Martiniano Baque, Mariano Volpacchio, Felipe Martinez Lomakin

Open access · goldAbstract read
In one paragraph

Article in Critical care (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Addition of 5% COAmerican journal of respiratory and critical care medicine · 2021
    Article
  12. Article
  13. Standardised PaOEuropean journal of internal medicine · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mario G SantamarinaRadiology Department, Hospital Naval Almirante Nef, Subida Alesandri S/N., Viña del Mar, Provincia de Valparaíso, Chile. mgsantama@yahoo.com.ORCID 0000-0002-9667-1313
Dominique Boisier RiscalIntensive Care Unit, Hospital Naval Almirante Nef, Viña del Mar, Chile.
Ignacio BeddingsRadiology Department, Clinica Bupa Santiago, Santiago, Chile.
Roberto ContrerasIntensive Care Unit, Hospital San Martin de Quillota, Quillota, Chile.
Martiniano BaqueIntensive Care Unit, Hospital IESS Los Ceibos, Guayaquil, Ecuador.
Mariano VolpacchioRadiology Department, Centro de Diagnóstico Dr. Enrique Rossi, Buenos Aires, Argentina.
Felipe Martinez LomakinIntensive Care Unit, Hospital Naval Almirante Nef, Viña del Mar, Chile.
Hospital Naval Almirante Nef · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSubtraction CT angiography (sCTA) is a technique used to evaluate pulmonary perfusion based on iodine distribution maps. The aim of this study is to assess lung perfusion changes with sCTA seen in patients with COVID-19 pneumonia and correlate them with clinical outcomes. MATERIAL AND

methodsA prospective cohort study was carried out with 45 RT-PCR-confirmed COVID-19 patients that required hospitalization at three different hospitals, between April and May 2020. In all cases, a basic clinical and demographic profile was obtained. Lung perfusion was assessed using sCTA. Evaluated imaging features included: Pattern predominance of injured lung parenchyma in both lungs (ground-glass opacities, consolidation and mixed pattern) and anatomical extension; predominant type of perfusion abnormality (increased perfusion or hypoperfusion), perfusion abnormality distribution (focal or diffuse), extension of perfusion abnormalities (mild, moderate and severe involvement); presence of vascular dilatation and vascular tortuosity. All participants were followed-up until hospital discharge searching for the development of any of the study endpoints. These endpoints included intensive-care unit (ICU) admission, initiation of invasive mechanical ventilation (IMV) and death.

resultsForty-one patients (55.2 ± 16.5 years, 22 men) with RT-PCR-confirmed SARS-CoV-2 infection and an interpretable iodine map were included. Patients with perfusion anomalies on sCTA in morphologically normal lung parenchyma showed lower Pa/Fi values (294 ± 111.3 vs. 397 ± 37.7, p = 0.035), and higher D-dimer levels (1156 ± 1018 vs. 378 ± 60.2, p < 0.01). The main common patterns seen in lung CT scans were ground-glass opacities, mixed pattern with predominant ground-glass opacities and mixed pattern with predominant consolidation in 56.1%, 24.4% and 19.5% respectively. Perfusion abnormalities were common (36 patients, 87.8%), mainly hypoperfusion in areas of apparently healthy lung. Patients with severe hypoperfusion in areas of apparently healthy lung parenchyma had an increased probability of being admitted to ICU and to initiate IMV (HR of 11.9 (95% CI 1.55-91.9) and HR 7.8 (95% CI 1.05-61.1), respectively).

conclusionPerfusion abnormalities evidenced in iodine maps obtained by sCTA are associated with increased admission to ICU and initiation of IMV in COVID-19 patients.

Indexed as

Contrast MediaIodineAdultAgedCoronavirus InfectionsCOVID-19FemaleHumansMaleMiddle AgedPandemicsPerfusion ImagingPneumonia, ViralProspective StudiesTomography, X-Ray ComputedContrast MediaIodineAngiotensin converting enzyme 2Angiotensin IIComputed tomography angiographyCoronavirusCOVID-19VasoconstrictionVasoplegiaVentilation-perfusion ratio

Identifiers

PMID33087155
PMCPMC7576979
OpenAlexW3093851647

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.